Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity

被引:189
作者
Yokoo, Sachiko
Yonezawa, Atsushi
Masuda, Satohiro
Fukatsu, Atsushi
Katsura, Toshiya
Inui, Ken-Ichi [1 ]
机构
[1] Kyoto Univ Hosp, Fac Med, Dept Pharm, Sakyo Ku, Kyoto 6068507, Japan
[2] Kyoto Univ Hosp, Fac Med, Div Artificial Kidneys, Sakyo Ku, Kyoto 6068507, Japan
关键词
cisplatin; MATE1; nephrotoxicity; OCT2; oxaliplatin; renal accumulation;
D O I
10.1016/j.bcp.2007.03.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The mechanism of severe nephrotoxicity caused by cisplatin, but not carboplatin, oxaliplatin, and nedaplatin, is not fully understood. The renal accumulation and subsequent nephrotoxicity of platinum agents were examined in rats. Among these four drugs, only cisplatin induced nephrotoxicity at 2 days after its intraperitoneal administration. The urinary activity of N-acetyl-beta-D-glucosaminidase and expression of kidney injury molecule-1 mRNA and osteopontin were markedly enhanced in the cisplatin-treated rats. Although some markers were affected in the rats administered nedaplatin, only minor histological change was observed. The renal accumulation of cisplatin was much greater than that of the other drugs. In the in vitro study, the cellular accumulation of cisplatin and oxaliplatin was stimulated by the expression of rat (r) OCT2. Oxaliplatin was also transported by rOCT3. A luminal H+/organic cation antiporter, rMATE1 (multidrug and toxin extrusion) as well as human (h) MATE1 and hMATE2-K, stimulated the H+-gradient-dependent antiport of oxaliplatin, but not of cisplatin. Carboplatin and nedaplatin were not transported by these transporters. In conclusion, the nephrotoxicity of platinum agents was closely associated with their renal accumulation, which is determined by the substrate specificity of the OCT and MATE families. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:477 / 487
页数:11
相关论文
共 28 条
[1]   Urine N-acetyl-β-D-glucosaminidase -: A marker of tubular damage? [J].
Bosomworth, MP ;
Aparicio, SR ;
Hay, AWM .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (03) :620-626
[2]  
Boulikas T, 2003, ONCOL REP, V10, P1663
[3]   Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2 [J].
Ciarimboli, G ;
Ludwig, T ;
Lang, DF ;
Pavenstädt, H ;
Koepsell, H ;
Piechota, HJ ;
Haier, J ;
Jaehde, U ;
Zisowsky, J ;
Schlatter, E .
AMERICAN JOURNAL OF PATHOLOGY, 2005, 167 (06) :1477-1484
[4]   Biochemical modulation of cisplatin mechanisms of action:: Enhancement of antitumor activity and circumvention of drug resistance [J].
Fuertes, MA ;
Alonso, C ;
Pérez, JM .
CHEMICAL REVIEWS, 2003, 103 (03) :645-662
[5]  
Graham MA, 2000, CLIN CANCER RES, V6, P1205
[6]   DRUG EXCRETION MEDIATED BY A NEW PROTOTYPE OF POLYSPECIFIC TRANSPORTER [J].
GRUNDEMANN, D ;
GORBOULEV, V ;
GAMBARYAN, S ;
VEYHL, M ;
KOEPSELL, H .
NATURE, 1994, 372 (6506) :549-552
[7]   Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3 [J].
Hayer-Zillgen, M ;
Brüss, M ;
Bönisch, H .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 136 (06) :829-836
[8]   Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury [J].
Ichimura, T ;
Bonventre, JV ;
Bailly, V ;
Wei, H ;
Hession, CA ;
Cate, RL ;
Sanicola, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (07) :4135-4142
[9]   Expression of osteopontin in cisplatin-induced tubular injury [J].
Iguchi, S ;
Nishi, S ;
Ikegame, M ;
Hoshi, K ;
Yoshizawa, T ;
Kawashima, H ;
Arakawa, M ;
Ozawa, H ;
Gejyo, F .
NEPHRON EXPERIMENTAL NEPHROLOGY, 2004, 97 (03) :96-105
[10]   Cellular and molecular aspects of drug transport in the kidney [J].
Inui, K ;
Masuda, S ;
Saito, H .
KIDNEY INTERNATIONAL, 2000, 58 (03) :944-958